TRASYLOL Aprotinin 1,000,000 KIU/100mL Australia - inglese - Department of Health (Therapeutic Goods Administration)

trasylol aprotinin 1,000,000 kiu/100ml

link medical products pty ltd t/a link pharmaceuticals - aprotinin, quantity: 10000 kiu/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.

TRASYLOL 2,000,000 KIU/200mL Australia - inglese - Department of Health (Therapeutic Goods Administration)

trasylol 2,000,000 kiu/200ml

link medical products pty ltd t/a link pharmaceuticals - aprotinin, quantity: 10000 kiu/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.

TRASYLOL 500,000KIU/50mL injection vial Australia - inglese - Department of Health (Therapeutic Goods Administration)

trasylol 500,000kiu/50ml injection vial

link medical products pty ltd t/a link pharmaceuticals - aprotinin, quantity: 10000 kiu/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.